Search by Drug Name or NDC
NDC 00115-1753-08 Acitretin 25 mg/1 Details
Acitretin 25 mg/1
Acitretin is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Amneal Pharmaceuticals of New York LLC. The primary component is ACITRETIN.
MedlinePlus Drug Summary
Acitretin is used to treat severe psoriasis (abnormal growth of skin cells that causes red, thickened, or scaly skin). Acitretin is in a class of medications called retinoids. The way acitretin works is not known.
Related Packages: 00115-1753-08Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Acitretin
Product Information
| NDC | 00115-1753 |
|---|---|
| Product ID | 0115-1753_80d24efe-d863-40f0-bd2b-85718f6ad568 |
| Associated GPIs | 90250510000125 |
| GCN Sequence Number | 019142 |
| GCN Sequence Number Description | acitretin CAPSULE 25 MG ORAL |
| HIC3 | L1A |
| HIC3 Description | ANTIPSORIATIC AGENTS,SYSTEMIC |
| GCN | 13481 |
| HICL Sequence Number | 007827 |
| HICL Sequence Number Description | ACITRETIN |
| Brand/Generic | Generic |
| Proprietary Name | Acitretin |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Acitretin |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE |
| Route | ORAL |
| Active Ingredient Strength | 25 |
| Active Ingredient Units | mg/1 |
| Substance Name | ACITRETIN |
| Labeler Name | Amneal Pharmaceuticals of New York LLC |
| Pharmaceutical Class | Retinoid [EPC], Retinoids [CS] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA202552 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00115-1753-08 (00115175308)
| NDC Package Code | 0115-1753-08 |
|---|---|
| Billing NDC | 00115175308 |
| Package | 30 CAPSULE in 1 BOTTLE, PLASTIC (0115-1753-08) |
| Marketing Start Date | 2016-01-04 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 8.3315 |
| Pricing Unit | EA |
| Effective Date | 2023-12-20 |
| NDC Description | ACITRETIN 25 MG CAPSULE |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 4 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis